Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
GRACE Risk Score Validation
Author(s): Wei Juan Lim , Ji Ken Ow , Xian Pei Cheong , et al Added: 1 year ago

Vascular Disease and Surgery

MI/ACS
NT-proBNP in AMI
Author(s): Shirley Siang Ning Tan , Keng Tat Koh , Alan Yean Yip Fong , et al Added: 1 year ago

MI/ACS
High-sensitivity Cardiac Troponin in the Emergency Department
Author(s): Raja Ezman Raja Shariff , Sazzli Kasim , Subashini C Thambiah , et al Added: 1 year ago

Standards & Guidelines

MI/ACS
Growth Differentiation Factor-15 in Chronic Heart Failure
Author(s): Yee Ling Cham , Alan Yean Yip Fong , Joshua Bui Kiong Chung , et al Added: 11 months ago

Heart Failure
Andrew Grace
Dr Grace has developed one of the largest clinical practices in cardiac arrhythmia management in the UK and specialises in catheter ablation techniques particularly for atrial fibrillation. Dr Grace trained in medicine at St Thomas’ Hospital in London completing his PhD in Cambridge with post-doctoral studies as a Fulbright Scholar at the University of California. He was appointed Consultant… View more
Author(s): Parinda Kiel , Watthanai Laoakkha , Thananya Boonyasirinant , et al Added: 6 months ago

Imaging & Diagnostics

Prevention & Chronic Conditions
OPTIMUM Registry: PCI in Patients at Prohibitive Risk for CABG
Author(s): David Kandzari Added: 2 years ago
In this short video, Dr David E Kandzari (Piedmont Heart Institute, Atlanta, GA, US) discusses the easy outcomes from the OPTIMUM registry. The registry is a minimal risk observational study that uses a prospective cohort design to follow patients who have multivessel or left main coronary artery disease (CAD) and are deemed ineligible for coronary artery bypass surgery. The findings, presented… View more

Intervention
Every week in the UK at least 12 young people die of undiagnosed heart conditions. Since its formation in 1995, Cardiac Risk in the Young (CRY) has been working to reduce the frequency of young sudden cardiac death (YSCD). CRY supports young people diagnosed with potentially life-threatening cardiac conditions and offers bereavement support to families affected by YSCD. CRY promotes and develops… View more
ACC 23: The Evolut Low Risk Trial
Author(s): John Forrest Added: 1 year ago
ACC.23/WCC - We are joined onsite by Dr John Forrest (Yale Valve Clinic, US) in this short video, who outlines the three-year outcomes of the Evolut Low-Risk Trial(Medtronic Cardiovascular) (NCT02701283). This study aimed to compare transcatheter aortic valve replacement (TAVR) using Medtronic's TAVR valve with surgical aortic valve replacement (SAVR) in over 2000 patients with aortic stenosis… View more

Intervention